Allergan Plc (AGN) Stock Price & Overview

NYSE:AGN

Current stock price

193.02
+0.03 (+0.02%)
At close:
193.7
+0.68 (+0.35%)
After Hours:

The current stock price of AGN is 193.02 null. Today AGN is up by 0.02%. In the past month the price increased by 5.94%. In the past year, price increased by 37.71%.

AGN Key Statistics

52-Week Range114.27 - 202.215
Current AGN stock price positioned within its 52-week range.
1-Month Range181.6 - 196.45
Current AGN stock price positioned within its 1-month range.
Market Cap
63.504B
P/E
10.94
Fwd P/E
11.56
EPS (TTM)
17.64
Dividend Yield
1.53%

AGN Stock Performance

Today
+0.02%
1 Week
+1.73%
1 Month
+5.94%
3 Months
-2.05%
Longer-term
6 Months +6.48%
1 Year +37.71%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

AGN Stock Chart

Allergan Plc / AGN Daily stock chart

AGN Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to AGN. When comparing the yearly performance of all stocks, AGN is one of the better performing stocks in the market, outperforming 92.42% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
AGN Full Technical Analysis Report

AGN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AGN. There are concerns on the financial health of AGN while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AGN Full Fundamental Analysis Report

AGN Earnings

Next Earnings DateN/A
Last Earnings DateN/A
AGN Earnings History

AGN Forecast & Estimates


Analysts
Analysts62.6
Price TargetN/A
EPS Next Y-5.33%
Revenue Next YearN/A
AGN Forecast & Estimates

AGN Financial Highlights

Over the last trailing twelve months AGN reported a non-GAAP Earnings per Share(EPS) of 17.64. The EPS increased by 5.69% compared to the year before.


Income Statements
Revenue(TTM)16.10B
Net Income(TTM)-2.49B
Industry RankSector Rank
PM (TTM) -15.44%
ROA -2.81%
ROE N/A
Debt/Equity 0.31
Chartmill High Growth Momentum
EPS Q2Q%21.68%
Sales Q2Q%0.2%
EPS 1Y (TTM)5.69%
Revenue 1Y (TTM)2.44%
AGN financials

AGN Ownership

Ownership
Inst Owners0%
Shares329.00M
Float282.72M
Ins Owners0.18%
Short Float %N/A
Short RatioN/A
AGN Ownership

About AGN

Company Profile

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.

Company Info

Allergan Plc

CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK

DUBLIN L2 D17 E400

CEO: Brenton L. Saunders

Phone: 862-261-7000

Allergan Plc / AGN FAQ

Can you describe the business of Allergan Plc?

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.


What is the current price of AGN stock?

The current stock price of AGN is 193.02 null. The price increased by 0.02% in the last trading session.


What is the dividend status of Allergan Plc?

Allergan Plc (AGN) has a dividend yield of 1.53%. The yearly dividend amount is currently 2.96.


What is the ChartMill rating of Allergan Plc stock?

AGN has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.